Skip to content

COMPARISION BETWEEN ROLE OF NASYA (NASAL MEDICATION) AND CERVICAL TRACTION IN THE MANAGEMENT OF MANYASTAMBHA (NECK PAIN & STIFFNESS)

STUDY OF COMPARATIVE EFFICACY OF NASYA AND CERVICAL TRACTION IN THE MANAGEMENT OF MANYASTAMBHA

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/08/004870
Enrollment
30
Registered
2014-08-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Nasya Arha( fit) patients having signs and symptoms of Manyastambha, patients fit for cervical traction with limitation of cervical range of motion, cervical spondylosis, cervical rediculopathy.

Interventions

Intervention1: Nasya: Administration of Narayan Taila Nasya 8 drops (0.4 ml) in each nostrils daily for 14 Days between 4 pm to 6 pm in Group A Control Intervention1: Cervical Traction: Intermittent C

Sponsors

Nirmal Bhusal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having the signs and symptoms of Manyastambha Patients between the age group of 20 to 70 years Patients of both the sexes NasyaArha patient Patients fit for cervical traction withLimitation of Cervical spine range of motion Cervical Spondylosis Cervical Radiculopathy Patient willing for the treatment

Exclusion criteria

Exclusion criteria: Patients with major disorders that is traumatic infective and neoplastic conditions of spine Congenital anomalies involving the Cervical spine Viral infections like Polio Myelitis Transverse Myelitis Bacterial infections like TB spine Demyelinating diseases Fibromyalgia Motor neuron diseases that interfere with the course of treatment will be excluded from the study Patients undergoing other modalities of treatment for Manyastambhawill be excluded

Design outcomes

Primary

MeasureTime frame
improvement in subjective and objective parameterTimepoint: 30 days

Secondary

MeasureTime frame
To find the comparative efficacy of either treatment.Timepoint: 2 years

Countries

India

Contacts

Public ContactNirmal Bhusal

Bharati Vidyapeeth Deemed University pune

drsurendravedpathak@gmail.com7030309088

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026